Abstract:BACKGROUND:The number of end-stage renal disease patients with diabetes mellitus (DM) who are undergoing peritoneal dialysis is increasing. Peritoneal dialysis-associated peritonitis (PDAP) is a serious complication of peritoneal dialysis leading to technical failure and increased mortality in patients undergoing peritoneal dialysis. The profile of clinical symptoms, distribution of pathogenic organisms, and response of PDAP to medical management in the subset of end-stage renal disease patients with DM have not been reported previously. Discrepant results have been found in long-term prognostic outcomes of PDAP in patients with DM. We inferred that DM is associated with bad outcomes in PDAP patients. AIM:To compare the clinical features and outcomes of PDAP between patients with DM and those without. METHODS:In this multicenter retrospective cohort study, we enrolled patients who had at least one episode of PDAP during the study period. The patients were followed for a median of 31.1 mo. They were divided into a DM group and a non-DM group. Clinical features, therapeutic outcomes, and long-term prognostic outcomes were compared between the two groups. Risk factors associated with therapeutic outcomes of PDAP were analyzed using multivariable logistic regression. A Cox proportional hazards model was constructed to examine the influence of DM on patient survival and incidence of technical failure. RESULTS:Overall, 373 episodes occurred in the DM group (n = 214) and 692 episodes occurred in the non-DM group (n = 395). The rates of abdominal pain and fever were similar in the two groups (P > 0.05). The DM group had more infections with coagulase-negative Staphylococcus and less infections with Escherichia coli (E. coli) as compared to the non-DM group (P < 0.05). Multivariate logistic regression analysis revealed no association between the presence of diabetes and rates of complete cure, catheter removal, PDAP-related death, or relapse of PDAP (P > 0.05). Patients in the DM group were older and had a higher burden of cardiovascular disease, with lower level of serum albumin, but a higher estimated glomerular filtration rate (P < 0.05). Cox proportional hazards model confirmed that the presence of diabetes was a significant predictor of all-cause mortality (hazard ratio = 1.531, 95% confidence interval: 1.091-2.148, P < 0.05), but did not predict the occurrence of technical failure (P > 0.05). CONCLUSION:PDAP patients with diabetes have similar symptomology and are predisposed to coagulase-negative Staphylococcus but not E. coli infection compared those without. Diabetes is associated with higher all-cause mortality but not therapeutic outcomes of PDAP.

New-onset Glucose Disorders in Peritoneal Dialysis Patients: a Meta-Analysis and Systematic Review

New-onset glucose disorders caused by long-term peritoneal dialysis through activation of oxidative stress

Older Age, Higher Body Mass Index and Inflammation Increase the Risk for New-Onset Diabetes and Impaired Glucose Tolerance in Patients on Peritoneal Dialysis.

Influence of peritoneal transport characteristics on nutritional status and clinical outcome in Chinese diabetic nephropathy patients on peritoneal dialysis.

Diabetic Patients Could Do As Well As Non-Diabetic Patients Without Inflammation on Peritoneal Dialysis

Accumulation of Tissue Advanced Glycation End Products Correlated with Glucose Exposure Dose and Associated with Cardiovascular Morbidity in Patients on Peritoneal Dialysis

Interaction Effect Between Fasting Plasma Glucose and Lipid Profiles on Mortality of Peritoneal Dialysis Patients.

High blood glucose independent of pre-existing diabetic status predicts mortality in patients initiating peritoneal dialysis therapy

Comparison of New-Onset Cardiovascular Disease Between Diabetes Mellitus and Non-Diabetes Mellitus Patients in Peritoneal Dialysis and Investigation of Risk Factors for Its Incidence

A Meta-Analysis Of Icodextrin Versus Glucose Containing Peritoneal Dialysis In Metabolic Management Of Peritoneal Dialysis Patients

24-h Glycaemic profiles in peritoneal dialysis patients and non-dialysis controls with advanced kidney disease

Comparison of long-term outcomes between Chinese peritoneal dialysis patients with and without diabetes: A 10-year cohort study

Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis.

Fasting blood glucose level and risk of all‐cause and cause‐specific mortality in peritoneal dialysis patients

The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years

Standards of diabetes care and burden of hypoglycaemia in people with diabetes on peritoneal dialysis: Results from a real-world clinical audit

Current pattern of Chinese dialysis units: a cohort study in a representative sample of units.

Survival Rates in Patients with Diabetes on Peritoneal Dialysis in China

Comparison Of Long-Term Outcomes Between Peritoneal Dialysis Patients With Diabetes As A Primary Renal Disease Or As A Comorbid Condition

Comparison of Clinical Features and Outcomes in Peritoneal Dialysis-Associated Peritonitis Patients with and Without Diabetes: A Multicenter Retrospective Cohort Study.

Influence of Early-Onset Peritonitis on Mortality and Clinical Outcomes in ESRD Patients with Diabetes Mellitus on Peritoneal Dialysis: A Retrospective Multicenter Study